Corvus Pharmaceuticals, Inc. (CRVS)
10.90
-0.03
(-0.27%)
USD |
NASDAQ |
Oct 02, 16:00
10.91
+0.01
(+0.09%)
After-Hours: 20:00
Corvus Pharmaceuticals EPS Diluted (Quarterly) : -0.1944 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1944 |
| March 31, 2026 | -0.1521 |
| December 31, 2025 | -0.1485 |
| September 30, 2025 | -0.1226 |
| June 30, 2025 | -0.1028 |
| March 31, 2025 | -0.1322 |
| December 31, 2024 | -0.1772 |
| September 30, 2024 | -0.6029 |
| June 30, 2024 | -0.0714 |
| March 31, 2024 | -0.1163 |
| December 31, 2023 | -0.1357 |
| September 30, 2023 | -0.1225 |
| June 30, 2023 | -0.1369 |
| March 31, 2023 | -0.1691 |
| December 31, 2022 | -0.2108 |
| September 30, 2022 | -0.3186 |
| June 30, 2022 | -0.1796 |
| March 31, 2022 | -0.1782 |
| December 31, 2021 | -0.1984 |
| September 30, 2021 | -0.2429 |
| June 30, 2021 | -0.2782 |
| Date | Value |
|---|---|
| March 31, 2021 | -0.3355 |
| December 31, 2020 | 0.9247 |
| September 30, 2020 | -0.3321 |
| June 30, 2020 | -0.3606 |
| March 31, 2020 | -0.4398 |
| December 31, 2019 | -0.3758 |
| September 30, 2019 | -0.3744 |
| June 30, 2019 | -0.4428 |
| March 31, 2019 | -0.3975 |
| December 31, 2018 | -0.3593 |
| September 30, 2018 | -0.3609 |
| June 30, 2018 | -0.40 |
| March 31, 2018 | -0.6333 |
| December 31, 2017 | -0.58 |
| September 30, 2017 | -0.62 |
| June 30, 2017 | -0.73 |
| March 31, 2017 | -0.79 |
| December 31, 2016 | -0.55 |
| September 30, 2016 | -0.51 |
| June 30, 2016 | -0.43 |
| March 31, 2016 | -5.39 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
| Biogen, Inc. | 0.6557 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.96M |
| Total Expenses (Quarterly) | 17.96M |
| Enterprise Value | 702.42M |
| Earnings Yield | -5.67% |
| Normalized Earnings Yield | -5.667 |